Article metrics

Download PDFPDF

OP0233 EFFICACY, SAFETY, AND PHARMACODYNAMIC EFFECTS OF THE BRUTON’S TYROSINE KINASE INHIBITOR, FENEBRUTINIB (GDC-0853), IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS IN A PHASE 2 CONTROLLED STUDY
Free

 

Online download statistics by month:

Online download statistics by month: June 2020 to June 2021

AbstractFullPdf
Jun 20204707
Jul 202088010
Aug 202059010
Sep 202088012
Oct 2020103022
Nov 2020105012
Dec 20205709
Jan 202181013
Feb 202184013
Mar 2021155029
Apr 2021124018
May 202127011
Jun 20211014
Total10190180